ANXA5 and hepatocellular carcinoma: In conclusion, as summarized and schemed in Fig. 8, ANXA5 overexpression positively correlated with CRKI/II and RAC1 potentially promoted the clinical development and metastasis of HCC as well as tumorigenicity and lymph node metastasis in vivo.